Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
about
Small molecule screening in context: lipid-catalyzed amyloid formation.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Hydralazine induces stress resistance and extends C. elegans lifespan by activating the NRF2/SKN-1 signalling pathway.
P2860
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
@ast
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
@en
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
@nl
type
label
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
@ast
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
@en
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
@nl
prefLabel
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
@ast
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
@en
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
@nl
P2093
P2860
P356
P1433
P1476
Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.
@en
P2093
Brent Desutter
Hayley E Schall
Ian V J Murray
Janelle N Fawver
Jessica K Roberts
Joseph Tingling
Karen T Duong
Michael Kahle
Mukesh Maheshwari
P2860
P304
10371-10380
P356
10.1021/BI101249P
P407
P577
2010-11-17T00:00:00Z